ETS transcription factors and regulation of immunity

被引:131
作者
Gallant, Sarah [1 ]
Gilkeson, Gary [1 ]
机构
[1] Med Univ S Carolina, Dept Med, Div Rheumatol, Charleston, SC 29425 USA
关键词
ETS; Ets1; Ets2; GABP; Fli1; Elf1; MEF; ESE1; PU.1; SpiB; transcription factor; immunity;
D O I
10.1007/s00005-006-0017-z
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The ETS family is a diverse group of transcription factors that control the expressions of genes that participate in an array of cellular activities, ranging from mitosis to apoptosis. As a consequence of regulating these processes, most ETS factors are oncogenic. However, there is growing evidence that ETS factors are also essential to regulation of the immune system. Of the 29 recognized ETS factors, nine are known to regulate genes involved in immunity, including Ets1, Ets2, GABP, Fli1, Elf1, MEF, ESE1, PU.1, and SpiB. These ETS factors typically activate the transcription of genes associated with pathogen and tumor defense, but several also demonstrate ability to repress transcription. Ets1 and PU.1 appear to have the greatest impact on immunity, primarily through their control of immune cell development. Alterations of Fli1 and Elf1 expression are associated with autoimmunity, emphasizing the role of ETS factors as not only positive, but also negative regulators of immunity. This review summarizes the roles of ETS factors in development of the immune system, defense against pathogens and malignancies, and self-tolerance.
引用
收藏
页码:149 / 163
页数:15
相关论文
共 201 条
[1]  
AHNE B, 1994, J BIOL CHEM, V269, P17794
[2]   Cooperation among Stat1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fcγ receptor I in monocytes [J].
Aittomäki, S ;
Pesu, M ;
Groner, B ;
Jänne, OA ;
Palvimo, JJ ;
Silvennoinen, O .
JOURNAL OF IMMUNOLOGY, 2000, 164 (11) :5689-5697
[3]   ELF-1 interacts with and transactivates the IgH enhancer pi site [J].
Akbarali, Y ;
Oettgen, P ;
Boltax, J ;
Libermann, TA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (42) :26007-26012
[4]   The role of IL-18 in innate immunity [J].
Akira, S .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (01) :59-63
[5]   MHC class II signaling in antigen-presenting cells [J].
Al-Daccak, R ;
Mooney, N ;
Charron, D .
CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (01) :108-113
[6]   Myeloid development is selectively disrupted in PU.1 null mice [J].
Anderson, KL ;
Smith, KA ;
Conners, K ;
McKercher, SR ;
Maki, RA ;
Torbett, BE .
BLOOD, 1998, 91 (10) :3702-3710
[7]   Neutrophils deficient in PU.1 do not terminally differentiate or become functionally competent [J].
Anderson, KL ;
Smith, KA ;
Pio, F ;
Torbett, BE ;
Maki, RA .
BLOOD, 1998, 92 (05) :1576-1585
[8]   Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage [J].
Anderson, MK ;
Weiss, AH ;
Hernandez-Hoyos, G ;
Dionne, CJ ;
Rothenberg, EV .
IMMUNITY, 2002, 16 (02) :285-296
[9]   GABP factors bind to a distal interleukin 2 (IL-2) enhancer and contribute to c-Raf-mediated increase in IL-2 induction [J].
Avots, A ;
Hoffmeyer, A ;
Flory, E ;
Cimanis, A ;
Rapp, UR ;
Serfling, E .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (08) :4381-4389
[10]   Mouse models in the study of the Ets family of transcription factors [J].
Bartel, FO ;
Higuchi, T ;
Spyropoulos, DD .
ONCOGENE, 2000, 19 (55) :6443-6454